Table 2

Characteristics of the diet consumed at baseline and 12 weeks, by group

RSV+Fib

RSV

SIM/EZE+Fib

SIM+EZE

P-value

N = 28

N = 30

N = 28

n = 30


MUFA%1

Baseline

13.8 (0.7)

12.8 (0.7)

13.4 (1.0)

11.8 (0.7)

0.374

12 weeks

12.9 (0.6)

13.6 (0.8)

13.4 (0.5)

11.5 (0.6)

0.094

PUFA%1

Baseline

9.1 (0.6)

11.9 (1.0)

10.3 (0.8)

10.3 (1.0)

0.329

12 weeks

8.3 (0.8)

10.7 (1.1)

9.6 (0.6)

8.2 (0.7)

0.098

SAFA%1

Baseline

9.7 (0.6)

9.5 (0.6)

9.5 (0.5)

9.1 (0.6)

0.833

12 weeks

9.3 (0.5)

9.4 (0.5)

9.5 (0.7)

8.9 (0.7)

0.717

Trans FA%1

Baseline

0.3 (0.1)

0.4 (0.1)

0.3 (0.1)

0.3 (0.1)

0.608

12 weeks

0.3 (0.1)

0.4 (0.1)

0.4 (0.2)

0.4 (0.1)

0.237

Energy Kcal/day2

Baseline

1762 (116)

1766 (100)

1828 (156)

1741 (136)

0.001a

12 weeks

1653 (116)

1520 (85)

1585 (129)

1599 (102)

0.990b

Lipids%1

Baseline

36.1 (1.4)

37.3 (1.9)

36.3 (1.7)

34.3 (1.8)

0.941

12 weeks

33.9 (1.4)

36.9 (1.8)

35.7 (1.2)

31.4 (1.6)

0.041

Carbohydrates%1

Baseline

46.4 (1.9)

46.9 (2.1)

46.7 (2.3)

49.2 (2.1)

0.869

12 weeks

46.3 (1.5)

46.5 (1.6)

46.7 (1.7)

52.1 (1.8)

0.034

Proteins%1

Baseline

18 (1.3)

16.5 (1.0)

17.7 (1.3)

17.3 (0.9)

0.79

12 weeks

20 (1.0)

17.6 (0.9)

18.5 (1.2)

17.8 (0.8)

0.268

Cholesterol mg/day2

Baseline

214 (29)

200 (21)

197 (33)

210 (29)

0.203a

12 weeks

222 (29)

157 (12)

201 (34)

171 (22)

0.683b

Fibers g/day2

Baseline

20 (3)

17 (1)

22 (3)

16 (2)

0.853a

12 weeks

20 (2)

16 (1)

18 (2)

19 (2)

0.666a


Differences analyzed by Kruskal-Wallis test1 or General Linear Model-repeated measures followed by Tukey's test2, with p-values for comparisons abetween visits and bbetween groups.

MUFA = monounsaturated fatty acids; PUFA = polyunsaturated fatty acids; SAFA = saturated fatty acids; RSV = rosuvastatin 40 mg; Fib = fiber; SIM = simvastatin 40 mg; EZE = ezetimibe 10 mg; FA = fatty acids.

Ramos et al. Nutrition Journal 2011 10:80   doi:10.1186/1475-2891-10-80

Open Data